AstraZeneca's IL-33-targeting antibody tozorakimab has made the grade in two phase 3 chronic obstructive pulmonary disease (COPD) trials, raising the prospects of a class that has recorded some ...

Bestimmte Krankheiten können zu einer Pflegebedürftigkeit führen. Betroffene sollten dann einen Pflegeantrag stellen. Bei ...

AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has hit the mark in a pair of phase 3 trials, delivering broad efficacy with a mechanism that yielded mixed data for Roche and ...

Chronic obstructive pulmonary disease, or COPD, is often thought of as a condition that only affects longtime smokers. In reality, the disease reaches far beyond that group. Women are ...

Chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, according to the World Health Organization. It’s a common ...

Researchers have found a promising treatment breakthrough for chronic obstructive pulmonary disease (COPD) that avoids many of the drawbacks of current drugs, and it has come from an unexpected place.

“This new COPD diagnostic schema, which includes chest imaging, respiratory symptoms and spirometry, identified additional individuals at risk of poor respiratory outcomes,” said Bhatt, a professor in ...

Dietary approaches are shaping up as a key aspect of chronic obstructive pulmonary disease (COPD) management. COPD encompasses both extremes of weight. Obesity affects some 54% of patients in the U.S.

Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as those of smokers without the disease. These overloaded cells are larger and ...

May 23, 2025 -- The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD). It is the second biologic therapy approved for the condition, following the ...

For some patients with chronic obstructive pulmonary disease (COPD), summer can be one of the most stressful times of the year. Not only is allergy season in full swing, but rising temperatures and ...